The Outcome of Early Bi-Level Positive Airway Pressure (BiPAP) Use in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
DOI:
https://doi.org/10.52206/jsmc.2026.16.1.1209Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a major global health problem and a leading cause of morbidity and mortality worldwide. Acute exacerbations of COPD frequently result in acute hypercapnic respiratory failure, necessitating ventilatory support. Noninvasive ventilation (NIV), particularly bi-level positive airway pressure (BiPAP), has emerged as a preferred modality during acute exacerbations due to its ability to improve gas exchange, reduce the work of breathing, and decrease the need for invasive mechanical ventilation.
Objective: To determine the outcome of early Bi-level positive airway pressure (BiPAP) use in patients presenting with acute exacerbation of COPD at a tertiary care hospital in Karachi.
Methodology: This prospective observational cohort study was conducted in the Department of Medicine, Abbasi Shaheed Hospital, Karachi, from January 7, 2021, to June 7, 2021. A total of 118 patients aged 30–70 years with a diagnosis of COPD for more than one year, presenting with acute exacerbation and hypercapnic respiratory failure, were enrolled using non-probability consecutive sampling. Early BiPAP therapy was initiated alongside standard medical treatment. Clinical parameters and arterial blood gas values were monitored. Outcomes were categorized as successful or failed based on the need for invasive mechanical ventilation. Data were analyzed using SPSS version 16.
Results: Out of 118 patients, 96 (81.4%) achieved a successful outcome following early BiPAP therapy, while 22 (18.6%) experienced treatment failure. The mean age was 57.87 ± 15.64 years. Significant improvement was observed in post-NIV arterial pH, PaO₂, and PaCO₂ levels. Multivariate analysis demonstrated that post-NIV pH and PaCO₂ were independent predictors of BiPAP success (p < 0.05).
Conclusion: Early initiation of BiPAP in patients with acute exacerbation of COPD was generally well tolerated and associated with a high success rate. This noninvasive strategy has the potential to reduce the need for invasive mechanical ventilation, hospital morbidity, and healthcare costs.
Keywords: Acute COPD Exacerbation, Bi-Level Positive Airway Pressure, Noninvasive Ventilation.
References
Pahal P, Hashmi MF, Sharma S. Chronic obstructive pulmonary disease compensatory measures. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jun 26.
Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022;206(11):1317-1325. https://doi.org/10.1164/rccm.202204-0671PP
Chuchalin AG, Avdeev SN, Aisanov ZR, Belevskiy AS, Leshchenko IV, Ovcharenko SI, et al. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonologiya. 2022;32(3):356-392. https://doi.org/10.18093/0869-0189-2022-32-3-356-392
Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447-458. https://doi.org/10.1016/S2213-2600(21)00511-7
Alpaydin AO, Ozuygur SS, Sahan C, Tertemiz KC, Russell R. Thirty-day readmission after an acute exacerbation of chronic obstructive pulmonary disease is associated with cardiovascular comorbidity. Turk Thorac J. 2021;22(5):369. https://doi.org/10.5152/TurkThoracJ.2021.0189
Agusti A, Melen E, DeMeo DL, Breyer-Kohansal R, Faner R. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med. 2022;10(5):512-524. https://doi.org/10.1016/S2213-2600(21)00555-5
Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD executive summary. Respirology. 2023;28(4):316-338. https://doi.org/10.1111/resp.14486
O’Donnell DE, Parker CM. COPD exacerbations. 3: Pathophysiology. Thorax. 2006;61(4):354-361. https://doi.org/10.1136/thx.2005.041830
Bräunlich J, Köppe-Bauernfeind N, Petroff D, Franke A, Wirtz H. Nasal high-flow compared to non-invasive ventilation in treatment of acute acidotic hypercapnic exacerbation of chronic obstructive pulmonary disease: protocol for a randomized controlled noninferiority trial (ELVIS). Trials. 2022;23(1):28. https://doi.org/10.1186/s13063-021-05978-z
Ahmad H, Zaman M. An audit of the management of patients admitted with acute exacerbation of COPD at a tertiary care hospital. Pak J Chest Med. 2015;21(2):68-75.
Gay PC, Owens RL; ONMAP Technical Expert Panel. Executive summary: Optimal NIV Medicare Access Promotion. Chest. 2021;160(5):1808-1821. https://doi.org/10.1016/j.chest.2021.05.074
Li J, Ran L. Efficacy of non-invasive ventilation in chronic obstructive pulmonary disease management: a systematic review and meta-analysis of randomized controlled trials. BMC Pulm Med. 2025;25(1):485. https://doi.org/10.1186/s12890-025-03857-w
Chawla RK, Yadav V, Banerjee S, Chaudhary G, Chawla A. Predictors of success and failure of non-invasive ventilation use in type 2 respiratory failure. Indian J Tuberc. 2021;68(1):20-24. https://doi.org/10.1016/j.ijtb.2020.10.002
Shaheen M, Daabis RG, Elsoucy H. Outcomes and predictors of success of non invasive ventilation in acute exacerbation of COPD. Egypt J Bronchol. 2018;12:329-339. https://doi.org/10.4103/ejb.ejb_112_17
Bajaj A, Kumar S, Inamdar AH, Agrawal L. Non invasive ventilation in acute hypoxic respiratory failure in medical ICU: a study in rural medical college. Int J Crit Illn Inj Sci. 2019;9(1):36-42. https://doi.org/10.4103/IJCIIS.IJCIIS_40_18
Hussain R, Hashir M, Awan ZI, Abid N. Effect of BiPAP on outcomes in COPD patients with hypercapnic respiratory failure. Pak J Med Health Sci. 2018;12(2):839-841.
Zhang CH, Liu JH, Zhao JQ, Zhang ZH, Gu X. Effect of BiPAP therapy on COPD complicated with anxiety and depression. Pak J Med Sci. 2023;39(5):1502-1506. https://doi.org/10.12669/pjms.39.5.7259
Mehta AB, Douglas IS, Walkey AJ. Hospital NIV case volume and outcomes of acute COPD exacerbations. Ann Am Thorac Soc. 2016;13(10):1752-1759. https://doi.org/10.1513/AnnalsATS.201603-209OC
Zewari S, Vos P, van den Elshout F, Dekhuijzen R, Heijdra Y. Obesity in COPD: revealed and unrevealed issues. COPD. 2017;14(6):663-673. https://doi.org/10.1080/15412555.2017.1383978
Orbell SL, Morris JL, Scott PW, Baniak LM, Imes CC, Jeon B, et al. The triple overlap of COPD, severe obesity, and high risk of OSA: insights from an NHANES analysis. BMC Pulm Med. 2025;25(1):282. https://doi.org/10.1186/s12890-025-03752-4
Mahul M, Capdevila M, Galia F, De Jong A, Jaber S. Physiological comparison of non invasive ventilation and CPAP on inspiratory efforts after extubation in critically ill patients with morbid obesity: a post-hoc analysis. Ann Intensive Care. 2025;15(1):180. https://doi.org/10.1186/s13613-025-01603-3
Türk M, Aydo?du M, Gürsel G. Effects of modes, obesity, and body position on NIV success in ICU. Turk Thorac J. 2018;19(1):28-35. https://doi.org/10.5152/TurkThoracJ.2017.17036
Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, et al. Adherence to long-acting inhaled therapies among COPD patients. COPD. 2012;9(3):251-258. https://doi.org/10.3109/15412555.2011.650241
Lange P, Marott JL, Vestbo J, Ingebrigtsen TS, Nordestgaard BG. Socioeconomic status and COPD prognosis in Denmark. COPD. 2014;11(4):431-437. https://doi.org/10.3109/15412555.2013.869580
Jacobsen PA, Kragholm KH, Torp-Pedersen C, Janssen DJA, Spruit MA, Weinreich UM. Employment status, readmission, and mortality after COPD exacerbation. Int J Chron Obstruct Pulmon Dis. 2021;16:2257-2265. https://doi.org/10.2147/COPD.S319840
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
